The hedge fund sold off its shares following CHS’ rocky 2016. The for-profit hospital operator ended the third quarter with a net loss of $79 million, compared to a $52 million profit in the same period of 2015. CHS’ stock has fallen about 70 percent since the beginning of last year.
To improve its finances, CHS put a turnaround plan into place in 2016. In an attempt to trim its debt load, the company is selling 17 hospitals and other assets to generate an expected $1.2 billion in working capital. The company moved forward with that plan in recent months, divesting several hospitals and its home health business.
Founded in 2010 by Conan Laughlin, North Tide Capital has nearly $2.3 billion in assets under management.
More articles on healthcare finance:
100 things to know about Medicare reimbursement | 2017
Kaiser Permanente operating income grows as membership booms
A state-by-state breakdown of hospital adjusted expenses per inpatient day
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
